Drugs for Baldness? Ozempic Maker Novo Takes On Hair Loss

Published on September 22, 2026

Novo Nordisk A/S is eyeing the hair-loss market as the maker of Ozempic seeks to expand its direct-to-consumer pharmaceuticals business.

Continue reading on website
Other news

Inflation Tops Family Offices’ Worries, Citi Survey Finds

September 22, 2026
Family offices now see inflation as their No. 1 worry, underscoring how rising costs of goods and services are vexing even the richest investors.

Riskiest Stocks Lose Performance Edge as Interest Rates Climb

September 22, 2026
For most of this year, investors have flocked into small caps to diversify away from the concentrated AI trade. Rising interest rates are threatening to put a damper on that.